Clinical Trial Update: A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea [Phase 4]

View source ↗

Summary

Clinical trial comparing valdecoxib and piroxicam for primary dysmenorrhea; Phase 4 completed assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• Piroxicam (piroxicam)
• Valdecoxib (valdecoxib)

Snippet

Sponsor: Pfizer | Conditions: Dysmenorrhea | Phase 4 | Status: COMPLETED